A randomized, double-blind, placebo-controlled pilot study of Lactobacillus reuteri ATCC 55730 for the prevention of antibiotic-associated diarrhea in hospitalized adults

Journal of Clinical Gastroenterology

Volumn 45, Issue 9, 2011, Pages 785-789

  Cimperman, Lisa ^a   Bayless, Gina ^a   Best, Kathleen ^a   Diligente, Autumn ^a   Mordarski, Beth ^a   Oster, Melanie ^a   Smith, Meghann ^a   Vatakis, Felicia ^a   Wiese, Dawn ^c   Steiber, Alison ^b   Katz, Jeffry ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

antibiotic associated diarrhea; Lactobacillus reuteri; probiotics

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CEFTRIAXONE; CEFUROXIME; CLINDAMYCIN; MEROPENEM; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; PLACEBO; PROBIOTIC AGENT; SULTAMICILLIN; VANCOMYCIN;

ABDOMINAL CRAMP; ABSCESS; ADULT; AGE DISTRIBUTION; ANTIBIOTIC ASSOCIATED DIARRHEA; ARTICLE; BACTERIUM COLONY; BLOATING; BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DIGESTIVE TRACT PARAMETERS; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; HOSPITAL PATIENT; HUMAN; LACTOBACILLUS REUTERI; MALE; NAUSEA; PILOT STUDY; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; STOOL CONSISTENCY; STOOL FREQUENCY; VOMITING;

ADULT; AGED; ANTI-BACTERIAL AGENTS; COLONY COUNT, MICROBIAL; DIARRHEA; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HOSPITALS; HUMANS; LACTOBACILLUS REUTERI; LENGTH OF STAY; MALE; MIDDLE AGED; PILOT PROJECTS; SEVERITY OF ILLNESS INDEX;

EID: 80052932435     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3182166a42     Document Type: Article

References (27)

1. Wistrom J, Norrby RR, Myhre EB, et al. Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study. J Antimicrob Chemother. 2001;47:43-50. (Pubitemid 32058754)
2. Barbut F, Petit JC. Epidemiology of Clostridium difficile infections. Clin Microbiol Infect. 2001;7:405-410.
3. McFarland LV. Epidemiology, risk factors, and treatment for antibiotic-associated diarrhea. Dig Dis. 1998;16:292-307. (Pubitemid 128527395)
4. Fuller R. Probiotics in human medicine. Gut. 1991;32:439-442.
5. Saavedra J. Probiotics and infectious diarrhea. Am J Gastroenterol. 2000;95(Suppl):16S-18S.
6. Jenkins B, Holsten S, Bengmark S, et al. Probiotics: a practical review of their role in specific clinical scenarios. Nutr Clin Pract. 2005;20:262-270. (Pubitemid 43093071)
7. Marteau PR, de Vrese M, Cellier CJ, et al. Protection from gastrointestinal diseases with the use of probiotics. Am J Clin Nutr. 2001;73 (suppl):430s-436s. (Pubitemid 32113267)
8. Elmer GW, McFarland LV. Biotherapeutic agents in the treatment of infectious diarrhea. Gastroenterol Clin North Am. 2001;30:837-853.
9. Hickson M, D'Souza AL, Muthu N, et al. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ. 2007;335:80.
10. Surawicz CM, McFarland LV, Elmer G, et al. Treatment of recurrent Clostridium difficile colitis with vancomycin and Saccharomyces boulardii. Am J Gastroenterol. 1989;84: 1285-1287. (Pubitemid 19264721)
11. D'Souza AL, Rajkumar C, Cooke J, et al. Probiotics in the prevention of antibiotic associated diarrhoea: a meta-analysis. BMJ. 2002;324:1361-1366.
12. Cremonini F, Caro SD, Nista EC, et al. Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. Aliment Pharmacol ther. 2002;16:1461-1467. (Pubitemid 34953587)
13. Johnston BC, Supina AL, Vohra S. Probiotics for pediatric antibiotic-associated diarrhea: a meta-analysis of randomized placebo-controlled trials. CMAJ. 2006;175:377-383. (Pubitemid 44298980)
14. Szajewska H, Ruszczjski M, Radzikowski A. Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials. J Pediatr. 2006;149:367-372.
15. McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol. 2006;101: 812-822.
16. Johnston BC, Supina AL, Ospina M, et al. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev. 2007;2:CD004827. doi: 10.1002/ 14651858.
17. Jacobsen CN, Rosenfeldt N, Hayford AE, et al. Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected stains in humans. Appl Environ Microbiol. 1999;65:4949-4956.
18. Wolf BW, Wheeler KB, Ataya DG, et al. Safety and tolerance of Lactobacillus reuteri supplementation to a population infected with the human immunodeficiency virus. Food Chem Toxicol. 1998;36:1085-1094. (Pubitemid 29002891)
19. Valeur N, Engel P, Carbajal N, et al. Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract. Appl Environ Microbiol. 2004;70:1176-1181. (Pubitemid 38568246)
20. Temmerman R, Pot B, Huys G, et al. Identification and antibiotic susceptibility of bacterial isolates from probiotic products. Int J Food Microbiol. 2003;81:1-10. (Pubitemid 35335388)
21. Shornikova AV, Casas IA, Mykkanen H, et al. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr Infect Dis J. 1997;16:1103-1107. (Pubitemid 28006664)
22. Rosenfeldt V, Michaelsen KF, Jacobsen M, et al. Effect of probiotic Lactobacillus strains in acute diarrhea in a cohort of nonhospitalized children attending day-care centers. Pediatr Infect Dis J. 2002;21:417-419. (Pubitemid 34532936)
23. Weizman Z, Asli G, Alsheikh A. Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics. 2005;115:5-9. (Pubitemid 43046274)
24. Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997;32:920-924. (Pubitemid 27382038)
25. Heaton KW, O'Donnell LJ. An office guide to whole-gut transit time. Patients' recollection of their stool form. J Clin Gastroenterol. 1994;19:28-30. (Pubitemid 24222236)
26. McFarland LV, Surawicz CM, Greenberg RN, et al. Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. Am J Gastroenterol. 1995;90:439-448.
27. Thomas MR, Litin SC, Osmon DO, et al. Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: a randomized, placebo-controlled trial. Mayo Clin Proc. 2001;76:883-889.(Pubitemid 32825909)